Your partner for customized antibodies
Are you looking for a scalable, reliable and cost-effective way to produce recombinant antibodies in different formats – without animal systems? Our technology platform based on the diatom Phaeodactylum tricornutum offers you a powerful alternative to conventional expression systems.
Whether against new targets (after individual coordination), on the basis of known sequences or from provided hybridoma cells – we support you in the development and production of customized antibody solutions.
Solutions
Our service portfolio
Primary and secondary antibodies
Recombinant primary and secondary antibodies – with optional fusion partners such as HRP, AP, fluorophores (e.g. GFP) or epitope tags
Different antibody formats
Various antibody formats – IgG, scFv, nanobodies, scFv-Fc with individual couplings and modifications
More than
antibodies
More than antibodies – other recombinant proteins such as enzymes, ligands or reporters can also be realized
Do you have special requirements?
Whether diagnostic use, research requirements or individual format adaptation – we implement your wishes flexibly. Feel free to contact us – we look forward to your project!
Phaeobodies®
Phaeobodies® – antibodies from Phaeodactylum tricornutum
Correct folding & binding specificity
Our recombinant antibodies from Phaeodactylum tricornutum exhibit error-free assembly of heavy and light chain and achieve the same target binding as animal systems.
Stability & shelf life
In terms of thermal stability, long-term functionality and durability, our phaeobodies fully meet the requirements of conventional antibodies.
Seamless application
Whether as primary or secondary antibodies – you will not detect any functional deviations in your assays, but you will also benefit from sustainable, reproducible and cost-efficient production.
Practical evidence “hey mela®”
Our soon to be available hey mela® pregnancy test is based entirely on Phaeobodies®.
Versatile antibody formats
Primary antibodies – precision at a new level
Our platform allows the production of a wide variety of primary antibody formats – as complete IgGs, scFv, scFv-Fc or nanobodies – with optional fusion partners. We generate antibodies based on existing sequences, sequence hybridoma cells or carry out de novo selections by phage display for new targets on request.
Secondary antibodies – precise, recombinant, animal-free
We offer a selection of recombinant secondary antibodies against various species with functional signaling agents. In contrast to classical chemical conjugations, the coupling takes place directly as a fusion protein during expression – for a defined, homogeneous and reproducible molecular structure.
Many of our secondary antibodies are based on high-affinity nanobody formats and are characterized by excellent specificity and stability – ideal for demanding applications in diagnostics and research.
Possible mergers:
- HRP (horseradish peroxidase)
- AP (alkaline phosphatase)
- Fluorescent markers such as eGFP, tGFP
- Epitope tags
Workflow & Process
Your process at a glance:
Inquiry & Advice
Initial consultation to clarify needs and coordinate sequence generation.
Pilot-scale production
For initial validation, provision of a defined test quantity after approximately 15 weeks.
scaled production
If the evaluation is positive, production according to your specifications down to the gram range.
FAQ
Frequently asked questions:
Is there a difference in handling compared to conventional antibodies?
No, our Phaeobodies® have the same properties as conventional antibodies.
Are the antibodies compatible with common primary antibodies?
Yes – primary antibodies are reliably and specifically recognized.
Are they monoclonal antibodies?
Yes, we supply monoclonal antibodies of precisely defined specificity.
How is quality control carried out?
Each batch is tested and documented for purity, concentration and binding activity.
Ready to start your project?
Contact us – we will get back to you as soon as possible.
